1. Home
  2. UPLD vs NRSN Comparison

UPLD vs NRSN Comparison

Compare UPLD & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$3.34

Market Cap

12.2M

Sector

Technology

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.33

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPLD
NRSN
Founded
2010
2017
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.2M
14.2M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
UPLD
NRSN
Price
$3.34
$0.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.75
$8.50
AVG Volume (30 Days)
32.0K
472.2K
Earning Date
05-01-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
63.38
N/A
EPS
N/A
N/A
Revenue
$74,767,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.95
$583.67
P/E Ratio
N/A
N/A
Revenue Growth
6.95
N/A
52 Week Low
$0.50
$0.25
52 Week High
$6.65
$1.30

Technical Indicators

Market Signals
Indicator
UPLD
NRSN
Relative Strength Index (RSI) 33.99 37.86
Support Level $0.62 $0.25
Resistance Level $5.65 $0.74
Average True Range (ATR) 0.36 0.06
MACD -0.16 0.01
Stochastic Oscillator 3.45 11.96

Price Performance

Historical Comparison
UPLD
NRSN

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: